The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification

Clinical research in neurodevelopmental disorders remains reliant upon clinician and caregiver measures. Limitations of these approaches indicate a need for objective, quantitative, and reliable biomarkers to advance clinical research. Extant research suggests the potential utility of multiple candi...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	James C. McPartland, Raphael A. Bernier, Shafali S. Jeste, Geraldine Dawson, Charles A. Nelson, Katarzyna Chawarska, Rachel Earl, Susan Faja, Scott P. Johnson, Linmarie Sikich, Cynthia A. Brandt, James D. Dziura, Leon Rozenblit, Gerhard Hellemann, April R. Levin, Michael Murias, Adam J. Naples, Michael L. Platt, Maura Sabatos-DeVito, Frederick Shic, Damla Senturk, Catherine A. Sugar, Sara J. Webb, the Autism Biomarkers Consortium for Clinical Trials
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2020-04-01
Cyfres:	Frontiers in Integrative Neuroscience
Pynciau:	autism spectrum disorder biomarker neuroscience clinical trial methodology/study design EEG ERP
Mynediad Ar-lein:	https://www.frontiersin.org/article/10.3389/fnint.2020.00016/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!